[1] 张鹤山,李子荣.股骨头坏死诊断与治疗的专家建议[J].中华骨科杂志,2007,27(2):146-148.
[2] Poyner D,Marshall I,Brain SD.The CGRP Family. Lands, Bioscience. USA:Texas, 1999:173-252.
[3] 李瑞琦,张国平,李宜炯,等.兔激素性股骨头坏死模型的研究[J].现代中西医结合杂志,2013,22(28):3087-3089,3170.
[4] 周正丽,张潜,彭笳宸,等.液氮冷冻兔股骨头坏死模型制备新方法及可靠性评价[J].解剖学报,2012,43(2):284-288.
[5] Mont MA, Jones LC, Einhorn TA,et al.Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors.Clin Orthop Relat Res.1998;(355 Suppl): S314-335.
[6] Jones JP Jr.Alcoholism, hypercortisonism, fat embolism and osseous avascular necrosis. 1971.Clin Orthop Relat Res. 2001;(393):4-12.
[7] Chao YC, Wang SJ, Chu HC,et al.Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver.Alcohol Alcohol. 2003;38(5):431-436.
[8] Kim HK, Herring JA.Pathophysiology, classifications, and natural history of Perthes disease.Orthop Clin North Am. 2011;42(3):285-295.
[9] 陈演.股骨头坏死病因学研究的某些进展[J].华西医学,2009, 24(7):1899-1901.
[10] Aaron RK,Gray RL.Osteonecrosis:etiology,natural history, pathophysiology and diagnosid//Cailaghan JJ, Rosenberg AG,Rubash JE. Theaduhhip.2nd ed. Philadelphia: Lippincott Williams&Wilkins,2007:463-476.
[11] Jones LC, Hungerford DS.Osteonecrosis: etiology, diagnosis, and treatment.Curr Opin Rheumatol. 2004;16(4):443-449.
[12] Suh KT, Kim SW, Roh HL, et al.Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis.Clin Orthop Relat Res. 2005;(431):220-225.
[13] Bjurholm A, Kreicbergs A, Schultzberg M,et al. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells.J Bone Miner Res. 1992; 7(9):1011-1019.
[14] Michelangeli VP, Fletcher AE, Allan EH,et al.Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells.J Bone Miner Res. 1989; 4(2):269-272.
[15] Bernard GW, Shih C.The osteogenic stimulating effect of neuroactive calcitonin gene-related peptide.Peptides. 1990; 11(4):625-632.
[16] Vignery A, McCarthy TL.The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts.Bone. 1996;18(4): 331-335.
[17] Calland JW, Harris SE, Carnes DL Jr.Human pulp cells respond to calcitonin gene-related peptide in vitro.J Endod. 1997;23(8):485-489.
[18] Shih C, Bernard GW.Calcitonin gene related peptide enhances bone colony development in vitro.Clin Orthop Relat Res. 1997;(334):335-344.
[19] Villa I, Dal Fiume C, Maestroni A,et al.Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity.Am J Physiol Endocrinol Metab. 2003; 284(3):E627-633.
[20] Villa I, Mrak E, Rubinacci A,et al.CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway.Am J Physiol Cell Physiol. 2006;291(3):C529-537.
[21] Imai S, Matsusue Y.Neuronal regulation of bone metabolism and anabolism: calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone. Microsc Res Tech. 2002;58(2):61-69.
[22] Tippins JR, Morris HR, Panico M,et al.The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP).Neuropeptides. 1984;4(5):425-434.
[23] Chambers TJ, Magnus CJ.Calcitonin alters behaviour of isolated osteoclasts.J Pathol. 1982;136(1):27-39.
[24] Valentijn K, Gutow AP, Troiano N,et al.Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone. 1997;21(3):269-274.
[25] Cornish J, Callon KE, Bava U,et al.Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development.Bone. 2001;29(2):162-168.
[26] Ishizuka K, Hirukawa K, Nakamura H,et al.Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol.Neurosci Lett. 2005;379(1):47-51.
[27] 孙应明,罗颂椒,赵昱辉,等.降钙素基因相关肽对体外大鼠破骨细胞形成的影响[J].临床口腔医学杂志,2005,21(1):3-5.
[28] 徐琳,谭颖徽,王建华,等. 失神经支配兔下颌骨骨折愈合过程中CGRP对OPG/RANKL表达的影响[J].第三军医大学学报,2005, 27(10):988-990.
[29] Hukkanen M, Konttinen YT, Santavirta S,et al.Effect of sciatic nerve section on neural ingrowth into the rat tibial fracture callus. Clin Orthop Relat Res. 1995;(311):247-257.
[30] Figini M, Emanueli C, Grady EF,et al.Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas.Am J Physiol. 1997;272 (4 Pt 1):G785-793.
[31] Elefteriou F.Regulation of bone remodeling by the central and peripheral nervous system.Arch Biochem Biophys. 2008; 473(2): 231-236.
[32] Jones KB, Mollano AV, Morcuende JA,et al.Bone and brain: a review of neural, hormonal, and musculoskeletal connections. Iowa Orthop J. 2004;24:123-132.
[33] Elefteriou F.Neuronal signaling and the regulation of bone remodeling.Cell Mol Life Sci. 2005;62(19-20):2339-2349.
[34] Huebner AK, Keller J, Catala-Lehnen P,et al.The role of calcitonin and alpha-calcitonin gene-related peptide in bone formation.Arch Biochem Biophys. 2008;473(2):210-217.
[35] Gajda M, Litwin JA, Cichocki T,et al.Development of sensory innervation in rat tibia: co-localization of CGRP and substance P with growth-associated protein 43 (GAP-43).J Anat. 2005; 207(2):135-144.
[36] Hukkanen M, Konttinen YT, Santavirta S,et al.Rapid proliferation of calcitonin gene-related peptide- immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience. 1993 Jun;54(4):969-979.
[37] Schlomer JJ, Storey BB, Ciornei RT,et al.Calcitonin gene-related peptide inhibits early B cell development in vivo.J Leukoc Biol. 2007;81(3):802-808.
[38] Coderre TJ, Basbaum AI, Levine JD.Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents.J Neurophysiol. 1989; 62(1):48-58.
[39] Wang X, Han CD, Fiscus RR,et al.Hypotension- and endotoxin-induced alterations in calcitonin gene-related peptide: modulation by dexamethasone.Circ Shock. 1991; 34(2): 217-223. |